Next 10 |
home / stock / lbltf / lbltf news
Late in the trading day on Friday, July, 9, Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) issued an update on the company which has been unable to trade its stock for over a month. The company had originally made biologic products for use in the field of bone regeneration i...
Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“ Lattice Biologics ” or the “ Company ”) announces financial results for Q2 2021. Highlights of Six Months Ended March 31, 2021 Sales and Product Offerings ...
Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“Lattice” or the “Company”), an emerging leader in psilocybin research and cannabis company, today announced the formation of its Strategic Advisory Board, a group of respected business leaders that wi...
Lattice now positioned in the largest cannabis markets in Montana Finished product will be co-branded under Lattice and Firehouse brands Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“ Lattice ” or the “ Company ”),...
Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“ Lattice Biologics ” or the “ Company ”) announced today that the Company will change its business strategy to focus on the fast growing psychedelics and cannabis markets through the creat...
Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“ Lattice Biologics ” or the “ Company ”) announces that Mr. Donald McInnes has resigned as a director of the Company, effective immediately, so that he can focus his efforts on other profe...
Lattice Biologics (LBLTF): FQ1 GAAP EPS of $0.00.Revenue of $0.47M (-32.9% Y/Y)Press Release For further details see: Lattice Biologics reports FQ1 results
Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“ Lattice Biologics ” or the “ Company ”) announces financial results for Q1 2021. Highlights of Three Months Ended December 31, 2020 Sales and Product Offerings ...
Lattice Biologics (LBLTF): FY GAAP EPS of -C$0.01.Press Release For further details see: Lattice Biologics reports FY results
Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“ Lattice Biologics ” or the “ Company ”) announces financial results for Q4 2020 and year end 2020. Highlights of Year Ended September 30, 2020 Sales and Product Offerings ...
News, Short Squeeze, Breakout and More Instantly...
Lattice Biologics Ltd Company Name:
LBLTF Stock Symbol:
OTCMKTS Market:
Late in the trading day on Friday, July, 9, Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) issued an update on the company which has been unable to trade its stock for over a month. The company had originally made biologic products for use in the field of bone regeneration i...
Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“ Lattice Biologics ” or the “ Company ”) announces financial results for Q2 2021. Highlights of Six Months Ended March 31, 2021 Sales and Product Offerings ...
Lattice Biologics Ltd. ( TSX-V: LBL ) (OTCBB: LBLTF) (“Lattice” or the “Company”), an emerging leader in psilocybin research and cannabis company, today announced the formation of its Strategic Advisory Board, a group of respected business leaders that wi...